Nephrology Symposium, Seventh Annual

Miami, FL US
March 17, 2018

Many diseases affect kidney function.  The proper screening of chronic kidney disease and end stage renal disease in patients is crucial.  Physicians need to recognize the significance of minor changes in the serum creatinine, which translates to poor outcomes.  During this symposium physicians learn about the key discoveries driving clinical trials
 

Complete details at NephrologySymposium.BaptistHealth.net

Target Audience

Nephrologists, Emergency Medicine Physicians, Family Medicine Physicians, Internists, Hospitalists, Cardiologists, Endocrinologists, Nurses, Respiratory Therapists and other interested healthcare professionals.   
 

 

Learning Objectives

  • Explain key discoveries driving current clinical trials.
  • Describe the importance and the strategies when identifying clinically relevant targets.
  • Discuss recent advances in diagnosis of genetic disorders.
  • Identify case-based examples of how a genetic diagnosis can be used in the clinic. Summarize the guidelines for screening and management of diabetic kidney disease (DKD).
  • Summarize the guidelines for screening and management of diabetic kidney disease (DKD).
  • Explain the contribution of blood pressure control with different agents on DKD development and progression.
  • Describe how new biomarkers can help to stratify patients.
  • Summarize the contribution of different hypoglycemia agents on DKD development and progression.
  • Identify and diagnose AKI syndromes in critically ill patients.
  • Implement treatment plans for the AKI patient.
  • Examine novel treatments being investigated. 
Course summary
Available credit: 
  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Florida Board of Nursing
  • 4.00 Nurse Practitioners
  • 4.00 Florida Board of Respiratory Therapy
  • 4.00 General certificate of attendance
Course opens: 
01/17/2018
Course expires: 
04/20/2018
Event starts: 
03/17/2018 - 7:30am
Event ends: 
03/17/2018 - 12:20pm
Rating: 
0

7:30 a.m.        Breakfast and Registration

7:50 a.m.        Welcome and Introductions
                       James Loewenherz, M.D.

7:55 a.m.        International Welcome and Introductions
                       Galed Hakim, M.D.

8:00 a.m.        Podocyte targets for the practicing nephrologists
                       Alessia Fornoni, M.D., Ph.D.

8:50 a.m.        Genetics in Clinical Nephrology
                       Jai Radhakrishnan, M.D., M.S.

9:40 a.m.        Questions and Answers

10:00 a.m.      Break and Exhibits

10:20 a.m.      Diabetes and Kidney Disease
                       Alessia Fornoni, M.D., M.S.

11:00 a.m.      Acute Kidney Injury (AKI) in Critically Ill Patients
                       Jai Radhakrishnan, M.D., M.S.

11:50 a.m.      Questions and Answers

12:20 p.m.      Adjourn

Baptist Hospital of Miami
8900 N. Kendall Dr.
5MCVI
Miami, FL 33176
United States
+1 (305) 671-2690
 

Parking: The special-event parking area will be open next to the conference center. The entrance closest to 5 MCVI is located on the south side of the campus. Approach from SW 94 Street (accessible from SW 87 Avenue). At the first Baptist Hospital sign, turn right and make an immediate left. Look for special
event parking on the right.


Alessia Fornoni, M.D., Ph.D.
Professor of Medicine
Chief, Katz Family Division of Nephrology and Hypertension
Director, Peggy and Harold Katz Family Drug Discovery Center
University of Miami
Miami, Florida

Alessia Fornoni, M.D., Ph.D., indicated that she has relevant financial relationships with commercial interest companies. She will not include off-label or unapproved product usage in her presentation(s) or discussion(s).
    Grant/Research Support: Roche, BI, NIH
    Consultant: Variant Pharmaceutical, Ono, Pfeizer, BI, Astra-Zeneca, Roche, Merck and Johnson and Johnson.
    Stock Shareholder: Variant Pharmaceuticals

Jai Radhakrishnan, M.D., M.S.
Professor of Medicine, Columbia University
Clinical Chief, Division of Nephrology, NY Presbyterian Hospital
New York, New York

Jai Radhakrishnan, M.D., M.S., has indicated that neither he nor his spouse/partner have relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships.

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been approved for 4 credit hours by the Florida Boards of Medicine, Osteopathic Medicine and the Florida Council of Physician Assistants. CE Broker #20-634854.

Approved for a total of 4 contact hours by the Florida State Board of Nursing CE Broker Provider #50-182.

Available Credit

  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Florida Board of Nursing
  • 4.00 Nurse Practitioners
  • 4.00 Florida Board of Respiratory Therapy
  • 4.00 General certificate of attendance

Accreditation Period

Course opens: 
01/17/2018
Course expires: 
04/20/2018
Please login or register to take this course.

Registrations will be accepted Onsite

Required Hardware/software

Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.

Technical Support